Location: Home
  • search
  • go
  • Relate News
  • 12/10/2020NMPA Announces OTC Switch of Glucosamine Effervescent Tablets and Gran...
  • 12/10/2020China vs. India: the Fight for Pharma Supremacy
  • 12/10/2020Denovo Acquires a Novel Late-Stage Oncology Drug and Expands into Prot...
  • 12/9/2020Hogan Lovells: China's New Amended Patent Law and Draft Implementation...
  • 12/9/2020NMPA Withdrawals 115 Drug Approvals
  • 12/9/2020NHSA Sets Up Expert Bank for Regional Point-based Global Budgetary Man...
  • 12/9/2020Chi-Med Commences Construction of a Large-Scale Manufacturing Plant i...
  • 12/9/2020Immutep and EOC to Start Phase II Metastatic Breast Cancer Study
  • 12/9/2020JW Life Science Eyes Expedited Entry into the Chinese IV Fluid Market
  • 12/9/2020SELLAS and 3D Med Announce License Deal for Galinpepimut-S (GPS) and ...
  • 12/8/2020Nuance Pharma Closes Series D Financing
  • 12/8/2020PegBio Raises $122M in Lead-up to IPO
  • 12/8/2020Henlius Adalimumab Biosimilar Approved by NMPA
  • 12/8/2020JD Health Jumps 56% in Hong Kong Debut
  • 12/8/2020CDE Seeks Comments on Draft ICH Guidelines E9(R1), S5(R3) and S11
  • 12/8/2020Pfizer Files Two NDAs for New Indications of Its CDK 4/6 Inhibitor Ibr...
  • 12/8/2020UCB Gains Chinese Approval for New Indication of KEPPRA (Levetiracetam...
  • 12/8/2020SciNeuro Secures $100M to Focus on China's Untapped CNS Market
  • 12/8/2020Ascentage Announces Positive Data from Pivotal Phase II Studies of HQP...
  • 12/8/2020Everest Med Recommended Breakthrough Therapy Designation for Nefecon i...
  • 12/8/2020Legend Biotech Announces Phase 1b/2 Study Data of BCMA CAR-T Cilta-cel...
  • 12/7/2020Amgen Launches Prolia (Denosumab Injection) in China
  • 12/7/2020China Approves Abbvie/Roche's BCL-2 Inhibitor Venetoclax
  • 12/7/2020NHSA: Volume-Based Drug Procurement Program Slashes Drug Costs Substan...
  • 12/7/2020Sinovac Gets $515M Investment from Sino Biopharma to Double Covid-19 V...
  • 12/7/2020Takeda Granted Chinese Approval of HAE Drug TAKHZYRO (Lanadelumab)
  • 12/7/2020BeiGene Announces Chinese Approval of BLINCYTO (Blinatumomab) 
  • 12/7/2020Nabriva and Sinovant Restructure License Deal for XENLETA for CABP i...
  • 12/7/2020Antengene Files Chinese IND for ATG-010 (Selinexor) in Combo with R-G...
  • 12/7/2020How Alibaba and JD.com Compare in Their Healthcare Endeavors
  • Page:211/777 Total number of articles:23303: [First][<<] [209] [210] [211] [212] [213] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group